Experts, Lawmakers Explore Downside of Drug-Price Negotiation https://www.medpagetoday.com/publichealthpolicy/medicare/107855 Stifled innovation, reduced access suggested as future challenges Potential unintended consequences of Medicare’s drug-price negotiation program were examined during a panel discussion hosted by The Hill and sponsored by the Alliance for Aging Research, an industry-funded nonprofit. Wednesday’s panelists raised concerns that drug-price negotiation under the Inflation […]
Filed under: General Problems | Leave a Comment »